Developing applications
to support healthier lives.

Dr. Paul Brunetta is a co-Founder of MACH, a Pulmonary and Critical Care physician, clinical researcher, and author with a robust background that spans over 14 years in clinical care and 22 years in biotechnology drug development. He is also a former smoker, which informs and drives his desire to help others understand nicotine addiction. Paul joined faculty at UCSF to focus on lung cancer research and tobacco related disease therapies.He is a co-founder of the Fontana Tobacco Treatment Center at UCSF and worked with Suzanne Harris,RN who is a master counselor in smoking cessation and a certified tobacco treatment specialist.Together they conceived of and published Learning to Quit, a resource that includes 2 dozen inspiring interviews with smokers that have successfully ended nicotine addiction along with important medical information useful to cigarette and e-cigarette users. He earned his Bachelor’s degree in Biology from Johns Hopkins University and an MD from Tufts University School of Medicine, with advanced residency and fellowship training in Internal Medicine and Pulmonary and Critical Care at UCSF.

Dr. Noreen Roth Henig is a Pulmonary and Critical Care physician, clinical researcher, and drug development leader committed to public health. Noreen oversees the strategic and operational development of MACH’s digital health platform, which offers medical guidance, educational content, and motivational coaching for smoking cessation. She focuses on expanding MACH's reach by building partnerships and integrating scientific advancements, aligning with MACH’s mission to provide accessible, evidence-based tools that enhance public health outcomes globally. She earned a Bachelor’s degree in History of Art from Yale University and an MD with Distinction in Immunology from the Albert Einstein College of Medicine, followed by training in Internal Medicine at UCSF and a fellowship in Pulmonary, Critical Care, and Allergy and Immunology at the University of Washington.

Greg Feldman has worked with MACH for 10 years, bringing his 21 years of experience in technology and content development within the biotech and pharmaceutical industries. Greg has held roles as Project Manager, Information Architect, and Director of Content Development, blending scientific precision with advanced technology to produce impactful educational content. At McGraw-Hill, he served as editor and project manager for Harrison’s Principles of Internal Medicine, overseeing sections on Infectious Disease and launching Harrison’s Online. At MACH, Greg focuses on technology-driven solutions for smoking cessation, leveraging his expertise to create accessible, engaging tools. He holds a Bachelor’s degree in English from Binghamton University and an MA in Journalism from the University of Colorado at Boulder.

Megan Goodman is a researcher and passionate about improving health care. Prior to MACH, Megan worked as a Senior Research Associate at Avidity Biosciences where she experienced the complexity of cross-functional biotech projects. This also reinforced her commitment to combine scientific rigor with real-world applications. Megan earned a Bachelor’s degree in Neuroscience from the University of Southern California and a Master of Science in Regulatory Science from Johns Hopkins University.